Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, Citigroup Analyst Says

Intuitive Surgical (NASDAQ:ISRG) had its price target lifted by analysts at Citigroup from $567.00 to $640.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Citigroup’s price objective indicates a potential upside of 17.72% from the stock’s current price.

A number of other equities research analysts also recently issued reports on the stock. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Raymond James raised their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Finally, Truist Financial raised their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $550.28.

Intuitive Surgical Stock Up 1.0 %

Shares of ISRG traded up $5.55 during trading hours on Wednesday, hitting $543.64. The company had a trading volume of 376,745 shares, compared to its average volume of 1,439,292. The firm has a market cap of $193.63 billion, a price-to-earnings ratio of 87.40, a PEG ratio of 5.41 and a beta of 1.38. The business has a fifty day moving average of $518.23 and a 200-day moving average of $476.59. Intuitive Surgical has a 12 month low of $314.38 and a 12 month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, equities analysts expect that Intuitive Surgical will post 5.45 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now directly owns 821 shares of the company’s stock, valued at $402,519.88. The trade was a 35.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the transaction, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. The trade was a 87.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,755 shares of company stock worth $26,273,943 over the last three months. 0.90% of the stock is owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Great Valley Advisor Group Inc. increased its position in shares of Intuitive Surgical by 8.3% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 2,477 shares of the medical equipment provider’s stock valued at $1,102,000 after purchasing an additional 189 shares during the last quarter. ORG Partners LLC boosted its position in shares of Intuitive Surgical by 3,411.1% during the 2nd quarter. ORG Partners LLC now owns 316 shares of the medical equipment provider’s stock valued at $138,000 after acquiring an additional 307 shares during the last quarter. Rockingstone Advisors LLC lifted its position in Intuitive Surgical by 0.5% in the second quarter. Rockingstone Advisors LLC now owns 8,748 shares of the medical equipment provider’s stock worth $3,892,000 after buying an additional 41 shares during the last quarter. Fiduciary Financial Group LLC bought a new stake in Intuitive Surgical in the second quarter worth $394,000. Finally, Valley National Advisers Inc. increased its stake in Intuitive Surgical by 29.3% in the second quarter. Valley National Advisers Inc. now owns 622 shares of the medical equipment provider’s stock worth $276,000 after purchasing an additional 141 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.